Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester

Table 1

Clinical and metabolic characteristics of study subjects.

	GDM ()	Controls ()	value
Maternal age, years	28.82 ± 0.67	27.37 ± 0.70	0.15
BMI before gestation, Kg/m^2	20.98 ± 0.51	19.74 ± 0.42	0.07
Gravidity	2.18 ± 0.27	1.64 ± 0.19	0.10
Parity	1.14 ± 0.14	1.20 ± 0.20	0.82
Triglycerides (mg/dL)
16–20 weeks	1.71 ± 0.11	1.77 ± 0.13	0.72
24–28 weeks	2.10 ± 0.12	2.32 ± 0.12	0.21
32–36 weeks	3.33 ± 0.24	3.29 ± 0.14	0.88
Total cholesterol (mg/dL)
16–20 weeks	5.54 ± 0.16	5.31 ± 0.13	0.28
24–28 weeks	6.39 ± 0.20	6.38 ± 0.16	0.97
32–36 weeks	6.33 ± 0.29	6.18 ± 0.24	0.68
LDL (mg/dL)
16–20 weeks	2.89 ± 0.17	2.82 ± 0.10	0.69
24–28 weeks	3.28 ± 0.16	3.35 ± 0.19	0.79
32–36 weeks	3.56 ± 0.21	3.15 ± 0.17	0.14
HDL (mg/dL)
16–20 weeks	1.98 ± 0.08	1.91 ± 0.06	0.50
24–28 weeks	2.02 ± 0.06	1.88 ± 0.05	0.62
32–36 weeks	1.94 ± 0.11	2.07 ± 0.06	0.26
(%)	5.15 ± 0.69	5.02 ± 0.05	0.11
OGTT fasting glucose (mmol/L)	4.25 ± 0.09	4.10 ± 0.08	0.22
OGTT 1-hour glucose (mmol/L)	8.94 ± 0.32	7.35 ± 0.25	0.00
OGTT 2-hour glucose (mmol/L)	9.01 ± 0.16	6.81 ± 0.22	0.00

Data are mean ± SD. ⁢.